Dr. Mary-Ann Etiebet is a global health innovator with over two decades of experience working across public and private sectors to improve health care outcomes for underserved populations. She joined MSD (known as Merck in the USA and Canada) in 2016, and now serves as the Associate Vice President, Health Equity & Partnerships, successfully building a new team responsible for the development and execution of the company’s first enterprise-wide health equity strategy, and now working to increase access to health and the company’s innovative portfolio of medicines and vaccines in low- and middle-income countries.
She previously served as the Lead and Executive Director of MSD for Mothers, MSD’s $650 million global health initiative that has increased access to quality maternal health care for more than 20 million women in over 65 countries. She is a member of the Center for Global Development Board of Directors, the Board of Trustees of Vital Strategies, and the Advisory Committee for the Pozen-Commonwealth Fund Fellowship in Health Equity Leadership at Yale University. She has also served as the private sector representative on the board of the World Health Organization- hosted Partnership for Maternal, Newborn & Child Health and the Investors Group of the World Bank’s Global Financing Facility.